quinoxalines has been researched along with 5,7-dihydroxytryptamine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Conway, S; Krulich, L; Mauceri, H; Moherek, R; Richardson, L; Speciale, S | 1 |
Reid, A; Sawynok, J | 1 |
Goldstein, DS; Kopin, IJ; Pacak, K; Yadid, G | 1 |
Amtage, F; Birthelmer, A; Cassel, JC; Ehret, A; Förster, S; Jackisch, R; Jeltsch, H; Lehmann, O | 1 |
4 other study(ies) available for quinoxalines and 5,7-dihydroxytryptamine
Article | Year |
---|---|
Interaction between norepinephrine and serotonin in the neuroendocrine control of growth hormone release in the rat.
Topics: 5,7-Dihydroxytryptamine; Adrenergic alpha-Agonists; Animals; Brimonidine Tartrate; Clonidine; Cyproheptadine; Fenclonine; Growth Hormone; Growth Hormone-Releasing Hormone; Hydroxyindoleacetic Acid; Hypothalamus; Male; Metergoline; Norepinephrine; Quinoxalines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Serotonin; Serotonin Antagonists | 1990 |
Spinal supersensitivity to 5-HT1, 5-HT2 and 5-HT3 receptor agonists following 5,7-dihydroxytryptamine.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analgesia; Analgesics; Analysis of Variance; Animals; Binding Sites; Indoles; Injections, Spinal; Male; Pain; Piperazines; Quinoxalines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Up-Regulation | 1994 |
Endogenous serotonin stimulates striatal dopamine release in conscious rats.
Topics: 5,7-Dihydroxytryptamine; Alanine; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Male; Microdialysis; Perfusion; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 1994 |
Neurotransmitter release and its presynaptic modulation in the rat hippocampus after selective damage to cholinergic or/and serotonergic afferents.
Topics: 5,7-Dihydroxytryptamine; Acetylcholine; Adrenergic alpha-Agonists; Animals; Antibodies, Monoclonal; Biogenic Monoamines; Brimonidine Tartrate; Choline O-Acetyltransferase; Cholinergic Agents; Cholinergic Fibers; Electric Stimulation; Hippocampus; Immunotoxins; Male; N-Glycosyl Hydrolases; Neurons, Afferent; Neurotoxins; Nicotine; Nicotinic Agonists; Norepinephrine; Organ Culture Techniques; Pyridines; Pyrroles; Quinoxalines; Rats; Rats, Long-Evans; Ribosome Inactivating Proteins, Type 1; Saporins; Serotonin; Serotonin Agents; Serotonin Receptor Agonists | 2003 |